Elevated activity of the HGF/c-Met pathway may represent a potent

Elevated activity of the HGF/c-Met pathway may represent a potential link between mesenchymal and CSC-like characteristics

in HCC. Although c-Met has been linked with liver CSC populations, the mechanism through which c-Met activation propagates CSC programs in mesenchymal cells has not been elucidated.24, 41 Using bulk HCC cell lines in vitro, c-Met–positive MHCC97-L and MHCC97-H cells demonstrate some liver CSC characteristics, such as resistance to chemotherapy and self-renewal capacity, as demonstrated by tumor sphere formation. This potential mesenchymal–CSC link is suggestive of recent work by Weinberg and colleagues34 in MLN0128 ic50 which breast cancer cells with mesenchymal phenotype demonstrated CSC characteristics. Interestingly, within bulk HCC cell populations, the expression of CD133 and EpCAM compared with CD44 appear to be inversely related. Future work on the differences in expression of these cell surface markers as related to tumor potential is planned. In this report specifically, inhibition of c-Met activity abolishes the capacity of self-renewal, as measured by tumor sphere assay, and suppresses CD44 expression.

In conclusion, c-Met inhibition may be an effective therapy for HCC in selected patients with strong c-Met expression but may not be of benefit Talazoparib chemical structure to HCC patients with c-Met–negative disease. In addition, within c-Met–positive HCC cells, further work is needed to determine the mechanism of survival that is observed after c-Met inhibition in vivo. We thank Jason Liao, Ph.D., Department of Biostatistics, Penn State College of Medicine, for assistance with statistical analysis. Additional Supporting Information may be found in the online version of this article. “
“Aim:  Virtual touch tissue quantification (VTTQ) is an implementation of ultrasound acoustic radiation force impulse imaging that provides numerical measurements of tissue

stiffness. We have evaluated the temporal changes of the remnant liver and spleen after living donor hepatectomy with special reference to the differences between right and left liver donation. Methods:  Nineteen living donors who received right lobectomy (small remnant liver [SRL] group; n = 7) or extended selleck compound left and caudate lobectomy (large remnant liver [LRL] group; n = 12) were enrolled. They underwent measurement of liver and spleen VTTQ before and after donor surgery. Results:  Virtual touch tissue quantification of the remnant liver increased postoperatively until postoperative day (POD) 3–5, and the values in the SRL group were significantly higher than those in the LRL group at POD 3–9. The values of the spleen also increased after donor surgery and the values in the SRL group were significantly higher than those in the LRL group at POD 3–14. A significant positive correlation between postoperative maximum value of VTTQ and postoperative maximum total bilirubin levels was observed.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>